Vol 15, No 5 (October 31, 2024): Journal of Gastrointestinal Oncology

Original Article

Clinical characteristics, survival and prognostic nomogram for patients with esophageal mucinous adenocarcinoma: a SEER population-based analysis
Zhikang Liu, Yuhang Yuan, Xiong Cao, Minjie Ma, Biao Han
Hepatoid adenocarcinoma of the stomach: discrimination from conventional gastric adenocarcinoma with a computed tomography-based radiomics nomogram
Xiaoyu Gu, Jian Rong, Li Zhu, Zhaoyan Dai, Shuai Ren, Jianxin Chen, Bo Yin, Zhongqiu Wang
Development of a streamlined NGS-based TCGA classification scheme for gastric cancer and its implications for personalized therapy
Pengda Guo, Yang Yang, Lu Wang, Yu Zhang, Bei Zhang, Jinping Cai, Fabrício Freire de Melo, Matthew R. Strickland, Min Huang, Biao Liu
Identifying a CD8T cell signature in the tumor microenvironment to forecast gastric cancer outcomes from sequencing data
Xiangyue Zeng, Tiannake Shapaer, Jianguo Tian, Abulajiang Abudoukelimu, Zeliang Zhao, Paerhati Shayimu, Binlin Ma
Metastasis patterns and prognosis in patients with gastric cancer: a Surveillance, Epidemiology, and End Results-based analysis
Qiumei Dong, Minqing Huang, Xiaorong Lai
Magnetic resonance imaging-based radiomics in predicting the expression of Ki-67, p53, and epidermal growth factor receptor in rectal cancer
Qiying Li, Jinkai Liu, Weneng Li, Mingzhu Qiu, Xiaohua Zhuo, Qikui You, Shaohua Qiu, Qi Lin, Yi Liu
Machine learning-based analysis identifies a 13-gene prognostic signature to improve the clinical outcomes of colorectal cancer
Dexu Xun, Xue Li, Lan Huang, Yuanchun Zhao, Jiajia Chen, Xin Qi
Changing of gamma-H2AX in peripheral blood mononuclear cells during concurrent chemoradiation in locally advanced rectal cancer patients: a potential response predictor
Piyapasara Toapichattrakul, Narongchai Autsavapromporn, Aphidet Duangya, Suwalee Pojchamarnwiputh, Wittanee Nachiangmai, Kittikun Kittidachanan, Somvilai Chakrabandhu
Characterizing PANoptosis gene signature in prognosis and chemosensitivity of colorectal cancer
Tingyu Zhao, Xiao Zhang, Xiao Liu, Xingyu Jiang, Silu Chen, Huiqin Li, Hongsheng Ji, Sumeng Wang, Qi Liang, Siqi Ni, Mulong Du, Lingxiang Liu
Construction of diagnostic models with machine-learning algorithms for colorectal cancer based on clinical laboratory parameters
Dengqing Si, Yu Shu, Hongbo Jiang, Xueping Lin, Qiurong Yuan, Shaotuan Deng, Wei Luo, Yangze Lin, Ju Wang, Chengxiong Zhan, Aasma Shaukat, Peter C. Ambe, Shiqiong Niu, Zhaofan Luo
Plasma levels of progranulin, a tumorigenic protein, are persistently elevated during the first month after minimally invasive colorectal cancer resection
HMC Shantha Kumara, Yanni Hedjar, Neil Mitra, Hiromichi Miyagaki, Xiaohong Yan, Vesna Cekic, Richard L. Whelan
Regorafenib monotherapy as the later-line treatment for elderly patients with metastatic colorectal cancer: a multicenter real-world study
Jinglong Huang, Caifeng Gong, Zhichao Jiang, Wang Qu, Yongkun Sun, Nan Zun Teo, Wen Zhang, Lin Yang, Yunbo Zhao, Aiping Zhou
Trans-arterial chemo-emobilization (TACE) combined with laparoscopic portal vein ligation and terminal branches portal vein embolization for hepatocellular carcinoma: a novel conversion strategy
Qing Yan, Feng-Jie Wang, Jia-Wei He, Jian-Yuan Hu, Eric C. H. Lai, Huan-Wei Chen
A predictive model based on radiomics, clinical features, and pathologic indicators for disease-free survival after liver transplantation for hepatocellular carcinoma: a 7-year retrospective study
Hao Xie, Bin Shi, Junzhen Fan, Shui Liu, Qiaozhi Ma, Junnan Dai, Siqing Dong, Ying Liu, Han Meng, Hui Liu, Ya Yang, Xuetao Mu
Nomogram-based prognostic stratification for patients with large hepatocellular carcinoma: a population study of SEER database and a Chinese cohort
Kun Ji, Hanlong Zhu, Cong Zhang, Jing Ai, Li Jing, Tiejian Zhao, Hui Tao, Feng Chen, Wei Wu
Real-world experience of lenvatinib-based therapy in patients with advanced hepatocellular carcinoma
Hung-Wei Wang, Hsueh-Chou Lai, Wen-Pang Su, Jung-Ta Kao, Wei-Fan Hsu, Hung-Yao Chen, Che-Wei Chang, Guan-Tarn Huang, Cheng-Yuan Peng
Identification of DLAT as a potential therapeutic target via a novel cuproptosis-related gene signature for the prediction of liver cancer prognosis
Cunbing Xia, Yang Chen, Yongkang Zhu, Dexuan Chen, Haijian Sun, Tong Shen, Vishal G. Shelat, Vasileios K. Mavroeidis, Giovanni Battista Levi Sandri, Zhan Wang, Hong Zhu
Evaluating the mitochondrial structure and gene expression profile of regenerated liver tissues in mice after 85% partial hepatectomy
Yongquan Shi, Yu Lei, Yanping Zhao, Shuaishuai Zhang, Hongxin Xu, Li Huo, Wei Liu, Qinlong Liu
Development and validation of a prognostic nomogram for elderly-onset pancreatic neuroendocrine carcinoma: a prospective cohort study from the SEER database
Haoxi Liu, Qian Zhang, Yitian Chen, Jie Xing, Xue Li, Haiyi Hu, Shutian Zhang, Rui Cheng
Initial adjustments in the dosage and rest period of gemcitabine plus cisplatin therapy for patients with incurable biliary tract cancer based on baseline estimated glomerular filtration rate (eGFR) values may be crucial for treatment outcomes and the preservation of renal function
Takanori Masumoto, Takuo Yamai, Kazuki Nakamura, Kohei Kamizono, Hiroki Sugioka, Tetsuro Miyazaki, Ryosuke Kiyota, Yuki Maegawa, Takeshi Shimizu, Shoichiro Kawai, Seiichi Tawara, Takuya Inoue, Takayuki Yakushijin
Application of integrin subunit genes in pancreatic cancer and the construction of a prognosis model
Qiuwen Ye, Tao Zhou, Xin Liu, Dong Chen, Burong Yang, Tingdong Yu, Jing Tan

Editorial Commentary

Peroxisome proliferator-activated receptor gamma (PPAR-γ) activation through gut microbiota modulation as a novel therapeutic approach against anastomotic leak after colorectal cancer surgery
María Ángeles Núñez-Sánchez, María Antonia Martínez-Sánchez, Bruno Ramos-Molina
Liposomal eribulin (E7389-LF) plus nivolumab: a potential treatment option for patients with advanced gastric cancer?
Ali Raza Shaikh, Daniel Lin
Negative hyperselection beyond RAS: is a key tool for choosing the optimal maintenance treatment in metastatic colorectal cancer?
Carles Pericay, Julen Fernández-Plana
The role of negative hyperselection in metastatic colorectal cancer
Jingran Ji, Marwan Fakih
DNA-dependent protein kinase inhibitor as a sensitizer of radiotherapy in locally advanced rectal cancer
Yoshinori Kagawa, Jun Watanabe, Koji Ando
Is the transverse colon the new right?—similarities in EGFR drug response and prognosis
Soledad Cameselle-García, Ana Fernández Montes
BCLC stage C hepatocellular carcinoma: modern therapeutic strategies in the age of immunotherapy
Victor Lopez-Lopez, Ignacio Sánchez-Esquer, Pablo Ramírez, Ricardo Robles-Campos